Guido Wollmann

Laboratory head

Medical University of Innsbruck

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Guido Wollmann is a Laboratory Head at the Medical University Innsbruck in Austria. His research focuses on cancer immunotherapy, specifically in the areas of anti-viral T cell responses, vaccine development, and combination treatments involving oncolytic viruses and small molecule therapeutics. Recent publications include studies on CD8 + T cell composition, antibody pharmacokinetics, and the implications of somatostatin receptor expression in nasopharyngeal carcinoma.

Articles (10)

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Kerry Chester

University College London

UNITED KINGDOM

View details

Dorothee von Laer

Medical University of Innsbruck

AUSTRIA

View details

Liam Masterson

UNITED KINGDOM

View details

Rajeev Gupta

University College London

UNITED KINGDOM

View details

Nischalan Pillay

Associate Clinical Professor

University College London

UNITED KINGDOM

View details

Christopher Bell

Reader (Associate Professor) in Functional Genomics & Epigenomics

Queen Mary University of London

UNITED KINGDOM

View details

Volker Schartinger

Medical University of Innsbruck

AUSTRIA

View details

Annika Rössler

University of Innsbruck

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Guido Wollmann

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Characterization of the Anti-Viral and Vaccine-Specific CD8<sup>+</sup> T Cell Composition upon Treatment with the Cancer Vaccine VSV-GP

Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP

Evaluating Antibody Pharmacokinetics as Prerequisite for Determining True Efficacy as Shown by Dual Targeting of PD-1 and CD96

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.

SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target

Chemogenetic ON and OFF switches for RNA virus replication

A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity

Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits

Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect

Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue

Collaborators (8)

Kerry Chester

Dorothee von Laer

Liam Masterson

Rajeev Gupta

Nischalan Pillay

Christopher Bell

Volker Schartinger

Annika Rössler

Make your next move.